Ultrasensitive DNA detection can help determine who they are
JCM | Free Full-Text | Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
Chronic myeloid leukemia (CML) - Bioscientia
A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib | PLOS ONE
Blood and Hematology - Molecular monitoring in CML: how deep? How often? How should it influence therapy? With the advent of tyrosine kinase inhibitors (TKIs), the goals of therapy in chronic myeloid
Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches
New Methodologies in the Molecular Monitoring of CML | SpringerLink
Chronic Myeloid Leukemia (CML): Focus on Molecular Monitoring
New approaches to molecular monitoring in CML (and other diseases) - ScienceDirect
Global Marketing Services on Twitter: "Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML). Provide results in hours, not weeks. For more information: https://t.co/8KSTbM64fq #Cepheid #GMSPakistan #CML
Full article: Molecular monitoring of chronic myeloid leukemia: present and future
Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post–Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients - Biology of Blood and Marrow Transplantation
Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia? | Haematologica
Chronic myeloid leukemia: cytogenetics and molecular biology's part in the comprehension and management of the pathology and treatment evolution | Egyptian Journal of Medical Human Genetics | Full Text
New approaches to molecular monitoring in CML (and other diseases) - ScienceDirect
PDF] Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. | Semantic Scholar
Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches